TY - JOUR
T1 - Compensatory evolution of Pseudomonas aeruginosa's slow growth phenotype suggests mechanisms of adaptation in cystic fibrosis
AU - La Rosa, Ruggero
AU - Rossi, Elio
AU - Feist, Adam M
AU - Johansen, Helle Krogh
AU - Molin, Søren
PY - 2021/5/27
Y1 - 2021/5/27
N2 - Long-term infection of the airways of cystic fibrosis patients with Pseudomonas aeruginosa is often accompanied by a reduction in bacterial growth rate. This reduction has been hypothesised to increase within-patient fitness and overall persistence of the pathogen. Here, we apply adaptive laboratory evolution to revert the slow growth phenotype of P. aeruginosa clinical strains back to a high growth rate. We identify several evolutionary trajectories and mechanisms leading to fast growth caused by transcriptional and mutational changes, which depend on the stage of adaptation of the strain. Return to high growth rate increases antibiotic susceptibility, which is only partially dependent on reversion of mutations or changes in the transcriptional profile of genes known to be linked to antibiotic resistance. We propose that similar mechanisms and evolutionary trajectories, in reverse direction, may be involved in pathogen adaptation and the establishment of chronic infections in the antibiotic-treated airways of cystic fibrosis patients.
AB - Long-term infection of the airways of cystic fibrosis patients with Pseudomonas aeruginosa is often accompanied by a reduction in bacterial growth rate. This reduction has been hypothesised to increase within-patient fitness and overall persistence of the pathogen. Here, we apply adaptive laboratory evolution to revert the slow growth phenotype of P. aeruginosa clinical strains back to a high growth rate. We identify several evolutionary trajectories and mechanisms leading to fast growth caused by transcriptional and mutational changes, which depend on the stage of adaptation of the strain. Return to high growth rate increases antibiotic susceptibility, which is only partially dependent on reversion of mutations or changes in the transcriptional profile of genes known to be linked to antibiotic resistance. We propose that similar mechanisms and evolutionary trajectories, in reverse direction, may be involved in pathogen adaptation and the establishment of chronic infections in the antibiotic-treated airways of cystic fibrosis patients.
KW - Adaptation, Physiological/drug effects
KW - Anti-Bacterial Agents/pharmacology
KW - Bacterial Proteins/genetics
KW - Cell Proliferation/drug effects
KW - Cystic Fibrosis/complications
KW - DNA Mutational Analysis
KW - DNA, Bacterial/genetics
KW - Directed Molecular Evolution
KW - Drug Resistance, Microbial/drug effects
KW - Evolution, Molecular
KW - Gene Expression Regulation, Bacterial
KW - Genetic Fitness/drug effects
KW - Genome, Bacterial
KW - Humans
KW - Lung/immunology
KW - Microbial Sensitivity Tests
KW - Mutation
KW - Phenotype
KW - Pseudomonas Infections/drug therapy
KW - Pseudomonas aeruginosa/drug effects
KW - Sputum/microbiology
UR - http://www.scopus.com/inward/record.url?scp=85106996746&partnerID=8YFLogxK
U2 - 10.1038/s41467-021-23451-y
DO - 10.1038/s41467-021-23451-y
M3 - Journal article
C2 - 34045458
VL - 12
SP - 3186
EP - 3200
JO - Nature Communications
JF - Nature Communications
SN - 2041-1722
IS - 1
M1 - 3186
ER -